NDC 0024-5841

ZALTRAP

Ziv-aflibercept

ZALTRAP is a Intravenous Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Aflibercept.

• Product ID: 0024-5841_1c018f0b-e1f4-4cc2-9a52-b5cee0e3dc97
• NDC: 0024-5841
• Product Type: Human Prescription Drug
• Proprietary Name: ZALTRAP
• Generic Name: Ziv-aflibercept
• Dosage Form: Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2012-08-03
• Marketing Category: BLA / BLA
• Application Number: BLA125418
• Labeler Name: sanofi-aventis U.S. LLC
• Substance Name: AFLIBERCEPT
• Active Ingredient Strength: 200 mg/8mL
• Pharm Classes: Vascular Endothelial Growth Factor Inhibitor [EPC],Vascular Endothelial Growth Factor Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0024-5841-01

1 VIAL in 1 CARTON (0024-5841-01) > 8 mL in 1 VIAL

• Marketing Start Date: 2012-08-03
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0024-5841-01 [00024584101]

ZALTRAP SOLUTION, CONCENTRATE

• Marketing Category: BLA
• Application Number: BLA125418
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2012-08-03

Drug Details

Active Ingredients

Ingredient	Strength
AFLIBERCEPT	200 mg/8mL

OpenFDA Data

• SPL SET ID: f6725df6-50ee-4b0a-b900-d02ba634395d
• Manufacturer:
  • sanofi-aventis U.S. LLC
• UNII:
  • 15C2VL427D
• RxNorm Concept Unique ID - RxCUI:
  • 1723193
  • 1723187
  • 1723189
  • 1723194

Pharmacological Class

• Vascular Endothelial Growth Factor Inhibitor [EPC]
• Vascular Endothelial Growth Factor Inhibitors [MoA]

NDC Crossover Matching brand name "ZALTRAP" or generic name "Ziv-aflibercept"

NDC	Brand Name	Generic Name
0024-5840	ZALTRAP	ziv-aflibercept
0024-5841	ZALTRAP	ziv-aflibercept